Hemolytic uremic syndrome–associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers
Open Access
- 15 December 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (13), 4199-4209
- https://doi.org/10.1182/blood-2005-05-2111
Abstract
Shiga toxin 1 (Stx-1) and Stx-2 produced by enterohemorrhagic Escherichia coli cause the diarrhea-associated hemolytic uremic syndrome (HUS). This type of HUS is characterized by obstruction of the glomeruli and renal microvasculature by platelet-fibrin thrombi, acute renal failure, thrombocytopenia, microvascular hemolytic anemia, and plasma levels of von Willebrand factor (VWF)-cleaving protease (ADAMTS13) activity that are within a broad normal range. We investigated the mechanism of initial platelet accumulation on Stx-stimulated endothelial cells. Stx-1 or Stx-2 (1-10 nM) stimulated the rapid secretion of unusually large (UL) VWF multimeric strings from human umbilical vein endothelial cells (HUVECs) or human glomerular microvascular endothelial cells (GMVECs). Perfused normal human platelets immediately adhered to the secreted ULVWF multimeric strings. Nanomolar concentrations (1-10 nM) of the Shiga toxins were as effective in inducing the formation of ULVWF-platelet strings as millimolar concentrations (0.1-20 mM) of histamine. The rate of ULVWF-platelet string cleavage by plasma or recombinant ADAMTS13 was delayed by 3 to 10 minutes (or longer) in the presence of 10 nM Stx-1 or Stx-2 compared with 20 mM histamine. Stx-induced formation of ULVWF strings, and impairment of ULVWF-platelet string cleavage by ADAMTS13, may promote initial platelet adhesion above glomerular endothelial cells. These processes may contribute to the evolution of glomerular occlusion by platelet and fibrin thrombi in diarrhea-associated HUS.Keywords
This publication has 88 references indexed in Scilit:
- Decrease of thrombomodulin contributes to the procoagulant state of endothelium in haemolytic uraemic syndromePediatric Nephrology, 2004
- Lepirudin prevents lethal effects of Shiga toxin in a canine modelThrombosis and Haemostasis, 2004
- Prophylactic heparinization is ineffective in a primate model of hemolytic uremic syndromePediatric Nephrology, 2002
- Molecular Basis for Up‐Regulation by Inflammatory Cytokines of Shiga Toxin 1 Cytotoxicity and Globotriaosylceramide ExpressionThe Journal of Infectious Diseases, 2002
- Function of von Willebrand Factor in Children with Diarrhea-Associated Hemolytic-Uremic Syndrome (D+ HUS)Seminars in Thrombosis and Hemostasis, 2001
- Coagulation Changes Associated with the Hemolytic Uremic SyndromeSeminars in Thrombosis and Hemostasis, 1998
- Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndromePediatric Nephrology, 1997
- Hemolytic Uremic Syndrome — Then and NowNew England Journal of Medicine, 1985
- Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancyThe Journal of Pediatrics, 1973
- Heparin therapy in the hemolytic-uremic syndromeThe Journal of Pediatrics, 1973